TP53 and cancer: One such potentialtarget for cancer therapy is the MDM2 protein, which plays a pivotalrole in regulating the activity of the tumor suppressor protein p53.The inhibition of the MDM2–p53 interaction has emerged as apromising strategy for developing new cancer treatments.